Pipeline

L.E.A.F. Pharmaceuticals currently has several new products in development, targeting solid tumors.  Investigational New Drug (IND) enabling Good Laboratory Practice (GLP) toxicology studies are currently underway for lead products, LEAF-1401 and LEAF-1701.

New Products in Development